1096 ASUNAPREVIR (ASV; BMS-650032), AN NS3 PROTEASE INHIBITOR, IN COMBINATION WITH PEGINTERFERON AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION

Journal of Hepatology ◽

10.1016/s0168-8278(12)61108-8 ◽

2012 ◽

Vol 56 ◽

pp. S431-S432 ◽

Author(s):

J.-P. Bronowicki ◽

S. Pol ◽

P. Thuluvath ◽

D. Larrey ◽

C.T. Martorell ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Protease Inhibitor ◽

Chronic Hepatitis C ◽

Hepatitis C Infection ◽

Treatment Naïve ◽

Peginterferon And Ribavirin ◽

Download Full-text

1163 A PHASE 2A STUDY OF BMS-791325, AN NS5B POLYMERASE INHIBITOR, WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION

Journal of Hepatology ◽

10.1016/s0168-8278(12)61175-1 ◽

2012 ◽

Vol 56 ◽

pp. S460 ◽

Author(s):

H. Tatum ◽

P. Thuluvath ◽

E. Lawitz ◽

C.T. Martorell ◽

M. Demicco ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Hepatitis C Infection ◽

Ns5b Polymerase Inhibitor ◽

Treatment Naïve ◽

Polymerase Inhibitor ◽

Peginterferon Alfa ◽

Ns5b Polymerase

Download Full-text

Work productivity among treatment-naïve patients with genotype 1 chronic hepatitis C infection receiving telaprevir combination treatment

Journal of Viral Hepatitis ◽

10.1111/jvh.12227 ◽

2014 ◽

Vol 22 (1) ◽

pp. 8-17 ◽

Author(s):

J. Aggarwal ◽

M. Vera-Llonch ◽

M. Donepudi ◽

E. Suthoff ◽

Z. Younossi ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Combination Treatment ◽

Work Productivity ◽

Hepatitis C Infection ◽

Treatment Naïve

Download Full-text

Cost-effectiveness analysis of simeprevir in combination with peginterferon and ribavirin for treatment-naïve chronic hepatitis C genotype 1 patients in Japan

Journal of Medical Economics ◽

10.3111/13696998.2015.1029492 ◽

2015 ◽

Vol 18 (7) ◽

pp. 502-511 ◽

Author(s):

Hiroyo Kuwabara ◽

Kirsten Westerhout ◽

Maarten Treur ◽

Karin Cerri ◽

Joerg Mahlich ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Treatment Naïve ◽

Peginterferon And Ribavirin

Download Full-text

Boceprevir: a novel nonstructural 3 (NS3) protease inhibitor for the treatment of chronic hepatitis C infection

Therapeutic Advances in Gastroenterology ◽

10.1177/1756283x11436317 ◽

2012 ◽

Vol 5 (3) ◽

pp. 179-188 ◽

Author(s):

Paul Y. Kwo

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Protease Inhibitor ◽

Chronic Hepatitis C ◽

Hepatitis C Infection ◽

Download Full-text

1195 BMS-650032, AN NS3 INHIBITOR, IN COMBINATION WITH PEGINTERFERON ALPHA-2A AND RIBAVIRIN IN TREATMENT-NAIVE SUBJECTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION

Journal of Hepatology ◽

10.1016/s0168-8278(11)61197-5 ◽

2011 ◽

Vol 54 ◽

pp. S472 ◽

Author(s):

J.-P. Bronowicki ◽

S. Pol ◽

P.J. Thuluvath ◽

D. Larrey ◽

C.T. Martorell ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Hepatitis C Infection ◽

Treatment Naïve

Download Full-text

Treating treatment-naïve Genotype 1 (G1) chronic Hepatitis C (CHC) patients with dual (Peginterferon/Ribavirin, P/R) or triple (P/R + Protease Inhibitor, PI) therapy in Hungary. An approach with limited financial resources

Zeitschrift für Gastroenterologie ◽

10.1055/s-0032-1312386 ◽

2012 ◽

Vol 50 (05) ◽

Author(s):

B Hunyady ◽

M Makara ◽

J Gervain ◽

G Horváth ◽

F Szalay ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Protease Inhibitor ◽

Chronic Hepatitis C ◽

Financial Resources ◽

Triple P ◽

Treatment Naïve

Download Full-text

Treatment of chronic hepatitis C Genotype 1 (G1) infection with boceprevir (Victrelis®) in the German real-life setting: First results for treatment-naïve patients from the Novus observational study

Zeitschrift für Gastroenterologie ◽

10.1055/s-0033-1352957 ◽

2013 ◽

Vol 51 (08) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Observational Study ◽

Chronic Hepatitis C ◽

Real Life ◽

Real Life Setting ◽

First Results ◽

Treatment Naïve

Download Full-text

Development of autoantibodies against “rings and rods”-associated IMPDH2 in chronic hepatitis C genotype 1 infection during protease inhibitor based triple therapy in a “real life” cohort

Zeitschrift für Gastroenterologie ◽

10.1055/s-0036-1597391 ◽

2016 ◽

Vol 54 (12) ◽

pp. 1343-1404

Author(s):

W Dammermann ◽

S Polywka ◽

I Dettmann ◽

S Mindorf ◽

L Komorowski ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Protease Inhibitor ◽

Triple Therapy ◽

Chronic Hepatitis C ◽

Real Life ◽

Download Full-text

Faculty of 1000 evaluation for Randomised clinical trial: pre-dosing with taribavirin before starting pegylated interferon vs. standard combination regimen in treatment-naïve patients with chronic hepatitis C genotype 1.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717965604.793466618 ◽

2012 ◽

Author(s):

Alex Thompson

Keyword(s):

Clinical Trial ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Randomised Clinical Trial ◽

Combination Regimen ◽

Treatment Naïve

Download Full-text

Faculty Opinions recommendation of Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718020296.793478787 ◽

2013 ◽

Author(s):

Arthur Kim

Keyword(s):

Hepatitis C ◽

Phase 2 ◽

Hepatitis C Infection ◽

Multicentre Phase ◽

Phase 2 Trial ◽

Treatment Naïve ◽

Peginterferon Alfa ◽

Download Full-text